Washington: American scientists have used a microchip to develop a device that mimics a living, breathing human lung.
Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard Medical School and Children's Hospital Boston collaborated to come up with the device.
About the size of a rubber eraser, it acts much like a lung in a human body and is made using human lung and blood vessel cells.
Because the lung device is translucent, it provides a window into the inner-workings of the human lung without having to invade a living body.
It has the potential to be a valuable tool for testing the effects of environmental toxins, absorption of aerosolised therapeutics and the safety and efficacy of new drugs.
Senior author Donald Ingber, founding director of Harvard's Wyss Institute, said: "The ability of the lung-on-a-chip device to predict absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens, provides proof-of-principle for the concept that organs-on-chips could replace many animal studies in the future."
He added: "We really can't understand how biology works unless we put it in the physical context of real living cells, tissues and organs."
The lung-on-a-chip microdevice takes a new approach to tissue engineering by placing two layers of living tissues-the lining of the lung's air sacs and the blood vessels that surround them-across a porous, flexible boundary.
Air is delivered to the lung lining cells, a rich culture medium flows in the capillary channel to mimic blood and cyclic mechanical stretching mimics breathing.
The device was created using a novel microfabrication strategy that uses clear rubbery materials. The strategy was pioneered by another Wyss core faculty member, George Whitesides, the Woodford L. and Ann A. Flowers University Professor at Harvard University.
First author Dan Huh, a Wyss technology development fellow at the Institute, said: "We were inspired by how breathing works in the human lung through the creation of a vacuum that is created when our chest expands, which sucks air into the lung and causes the air sac walls to stretch. Our use of a vacuum to mimic this in our microengineered system was based on design principles from nature."
To determine how well the device replicates the natural responses of living lungs to stimuli, the researchers tested its response to inhaled living E. coli bacteria.
They introduced bacteria into the air channel on the lung side of the device and at the same time flowed white blood cells through the channel on the blood vessel side. The lung cells detected the bacteria and, through the porous membrane, activated the blood vessel cells, which in turn triggered an immune response that ultimately caused the white blood cells to move to the air chamber and destroy the bacteria.
Rustem Ismagilov, professor of chemistry at the University of Chicago, who specializes in biochemical microfluidic systems, said: "The ability to recreate realistically both the mechanical and biological sides of the in vivo coin is an exciting innovation."
Huh said: "The team followed this experiment with a "real-world application of the device."
They introduced a variety of nano-scaled particles (a nanometer is one-billionth of a meter) into the air sac channel. Some of these particles exist in commercial products; others are found in air and water pollution.
Several types of these nanoparticles entered the lung cells and caused the cells to overproduce free radicals and to induce inflammation. Many of the particles passed through the model lung into the blood channel, and the investigators discovered that mechanical breathing greatly enhanced nanoparticle absorption. Benjamin Matthews, Harvard Medical School assistant professor in the Vascular Biology Program at Children's Hospital Boston, verified these new findings in mice.
Huh said: "Most importantly, we learned from this model that the act of breathing increases nanoparticle absorption and that it also plays an important role in inducing the toxicity of these nanoparticles."
Robert Langer, MIT Institute professor, said: "This lung-on-a-chip is neat and merges a number of technologies in an innovative way. I think it should be useful in testing the safety of different substances on the lung and I can also imagine other related applications, such as in research into how the lung functions."
According to Ismagilov, it's too early to predict how successful this field of research will be. Still, "the potential to use human cells while recapitulating the complex mechanical features and chemical microenvironments of an organ could provide a truly revolutionary paradigm shift in drug discovery," he said.
The research appears in the June 25 issue of Science.